ASX 300

Chinese imports soared 31% year on year in September, with mixed returns for Australia.

Different strategies are increasingly backing the same stocks. Plato’s Chanel Stuart-Findlay explains why diversification matters more.

An inevitable end to a famous Australian institution.

Plus, Flanagan’s Arrow builds iron ore base and government grant puts Australian Vanadium in box seat to win Kalgoorlie battery tender.

Strong earnings are meeting tougher expectations. The bill for future growth is bringing quality investing into sharper focus.

Matt Riordan (Paradice) and Marcus Burns (Spheria) debate which high-flying ASX winners are still worth paying up for.

The Australian property sector has historically trumped the S&P/ASX 200 by double digits following peaks in the interest rate cycle.

Woodside has just announced new rules for how it pays shareholders - is that a positive or a dividend cut in disguise?

Facing economic headwinds to profit growth in light of rising cost of living pressures, RBA rate hikes, and a declining property market, how have the banks performed?...

Uranium investors have endured a brutal ride, even as the fundamental case for nuclear power continues to improve.

Can these 5 beaten-down stocks rebound? Matt Riordan of Paradice and Marcus Burns from Spheria weigh in.

RQI’s Dr David Walsh on why value is winning, the AI risk he’s watching, and why his model still avoids WiseTech and Treasury Wine Estates.

As tech stocks sink, Berkshire Hathaway and five ASX-listed investments are weathering the storm like ocean liners.

US stocks now make up half of the stocks Aussies trade most – here's why, and how you can get your slice of the Wall St pie.

Uranium is also getting a glow as producers and investors await a surge of buying from electricity generators.

Upgrades for consumer staples and agriculture, downgrades for industrials and healthcare. Morgans' sector views and the stocks backing them.

Two fund managers test the defensive credentials of Coles, Telstra, HMC Capital and Pro Medicus, then share two more stocks they’re backing.

Seeing the forest for the trees remains more important than ever.

US data centre stocks tumble after the Democratic midterm sweep, while ASX operators rally as investors reassess global AI infrastructure.

Firmus, AirTrunk and NEXTDC have all hit funding hurdles. Matthew Kidman says that's the real risk for AI stocks, so he's getting defensive.

The RBA hiked interest rates on Melbourne Cup Day - that sounds bad for consumers but beaten down retail stocks caught a hot bid.

Small caps trail large caps by a margin seen only three times since 2002. AGM insights and five catalysts that could spark a rebound.

Why lithium miners such as PLS, Liontown, and Vulcan Energy presently fit our contrarian investment approach.

Nothing tests an investor's nerves more than a cratering growth stock. Here is how TMS Ben Clark's survives and thrives from those moments.